Publicação: In situ synthesis of piperine-loaded MIL-100 (Fe) in microwave for breast cancer treatment
dc.contributor.author | Quijia, Christian Rafael [UNESP] | |
dc.contributor.author | Tavares Luiz, Marcela | |
dc.contributor.author | Fernandes, Richard Perosa [UNESP] | |
dc.contributor.author | Sábio, Rafael Miguel [UNESP] | |
dc.contributor.author | Frem, Regina [UNESP] | |
dc.contributor.author | Chorilli, Marlus [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.date.accessioned | 2023-03-02T10:44:17Z | |
dc.date.available | 2023-03-02T10:44:17Z | |
dc.date.issued | 2022-09-01 | |
dc.description.abstract | Piperine (PIP) is a natural alkaloid that has strong activity against breast cancer. However, due to its low solubility and bioavailability, it is unfeasible for clinical applications. Herein, we proposed an in-situ method for PIP encapsulation into the Materials of the Institut Lavoisier (MIL-100 (Fe)) using microwaves technique for fabricating novel drug delivery nanocarriers. The PIP-loaded MIL-100 (Fe) (labeled PIP@MIL-100 (Fe)) exhibited a hydrodynamic diameter of 98 ± 27.83 nm, zeta potential of +7 ± 0.6 mV, and polydispersity index of 0.03 ± 0.006. Morphological analysis of the nanosystems revealed a rhombohedral shape and particle size up to 120 nm. PIP encapsulation efficiency (EE) was found to be 95 ± 3% and PIP loading capacity was 11.02% by weight (0.12 g g−1), according to high-performance liquid chromatography (HPLC) and thermogravimetric analysis (TGA) data, respectively. Cytotoxicity studies on breast cancer cell lines (MCF-7 and 4T1) displayed cytotoxicity (IC50) approximately three times higher than that of the free PIP within 48 h. The PIP@MIL-100(Fe) fabrication comprises a simple and cheap method for designing novel drug delivery nanosystems for further clinical assays and breast cancer treatment. | en |
dc.description.affiliation | School of Pharmaceutical Sciences São Paulo State University (UNESP), São Paulo | |
dc.description.affiliation | School of Pharmaceutical Science of Ribeirão Preto University of São Paulo (USP), Ribeirão Preto | |
dc.description.affiliation | Institute of Chemistry São Paulo State University (UNESP), São Paulo | |
dc.description.affiliationUnesp | School of Pharmaceutical Sciences São Paulo State University (UNESP), São Paulo | |
dc.description.affiliationUnesp | Institute of Chemistry São Paulo State University (UNESP), São Paulo | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorshipId | FAPESP: 2018/21119–0 | |
dc.identifier | http://dx.doi.org/10.1016/j.jddst.2022.103718 | |
dc.identifier.citation | Journal of Drug Delivery Science and Technology, v. 75. | |
dc.identifier.doi | 10.1016/j.jddst.2022.103718 | |
dc.identifier.issn | 1773-2247 | |
dc.identifier.scopus | 2-s2.0-85136241995 | |
dc.identifier.uri | http://hdl.handle.net/11449/242170 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Drug Delivery Science and Technology | |
dc.source | Scopus | |
dc.subject | 4T1 cells | |
dc.subject | Breast cancer treatment | |
dc.subject | MCF-7 cells | |
dc.subject | Metal-organic framework-based | |
dc.subject | Nanoparticles | |
dc.title | In situ synthesis of piperine-loaded MIL-100 (Fe) in microwave for breast cancer treatment | en |
dc.type | Artigo | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isDepartmentOfPublication.latestForDiscovery | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
unesp.author.orcid | 0000-0002-4370-8960[1] | |
unesp.author.orcid | 0000-0002-6698-0545[6] | |
unesp.department | Fármacos e Medicamentos - FCF | pt |